TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$10.610-0.170 (-1.577%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$10.780

High

$10.780

Low

$10.520

Volume

0.00M

Company Fundamentals

Market Cap

530.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.28M

Exchange

NGM

Currency

USD

52-Week Range

Low $7.44Current $10.610High $11.82

Related News

PR Newswire

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3...

View more
Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress
PR Newswire

Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first...

View more
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
PR Newswire

Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of...

View more
Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress
PR Newswire

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2025 financial results and provide a business update after market close on...

View more
Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025